HUTCHMED (China) Return on Equity (ROE) Growth & History (HCM)

HUTCHMED (China)'s return on equity was 45.74% for fiscal 2025.

View full HUTCHMED (China) company overview

HUTCHMED (China) annual return on equity history

HUTCHMED (China) annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-3145.74%+40.68 pp
20242024-12-315.06%−9.97 pp
20232023-12-3115.03%+60.21 pp
20222022-12-31−45.18%−18.72 pp
20212021-12-31−26.46%+6.10 pp
20202020-12-31−32.57%−1.25 pp
20192019-12-31−31.32%−13.74 pp
20182018-12-31−17.59%−9.31 pp
20172017-12-31−8.28%−17.02 pp
20162016-12-318.74%−2.65 pp
20152015-12-3111.40%

HUTCHMED (China) return on equity trends

Over the last five fiscal years, HUTCHMED (China)'s return on equity increased from −32.57% to 45.74%, a change of +78.31 percentage points. The latest reported quarter, Q4 2019, shows −9.83%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review HUTCHMED (China) source filings ↗

Community posts

It’s quiet here.

No posts about HCM yet. Start the conversation.

Write the first post